Cryomass Technologies logo

Cryomass Technologies(OTC) CRYM

Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Cryomass Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-01
Cryomass Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-21
1 month+0%USD 0.002026-09-01
3 month+0%USD 0.002026-06-30
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-10-01
3 year-100%USD 0.082023-10-02
5 year-100%USD 0.272021-10-01
Since inception-100%USD 0.582014-06-03

Cryomass Technologies Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$37.74K

Net Income (TTM)

-$8.82M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

245.49 (High)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 6, 2025

CRYM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cryomass Technologies

Cryomass Technologies Inc. is a specialized company focused on the development and commercialization of cryo-mechanical systems for processing premium botanical materials, including hemp and cannabis. Established in 2011 and based in Denver, Colorado, the company has undergone significant rebranding and strategic shifts to enhance its market position.

Products and Services
  • Cryo-mechanical systems for processing botanical materials
  • Innovative solutions tailored for the hemp and cannabis industries
  • Research and development in advanced processing technologies
Growth Outlook
  • Recent quarterly revenue increased to $5,000, showing potential for growth
  • Market demand for cannabis processing solutions continues to rise
  • Strategic focus on expanding product offerings in the botanical sector
Financial Highlights
  • Trailing twelve months revenue of $50,000, indicating a growing business
  • Net income for Q3 2024 reported at -$1,101,933, reflecting ongoing investment
  • Cash and cash equivalents at $183,439, providing liquidity for operations
Cryomass Technologies Inc. operates in the Drug Manufacturers - Specialty & Generic industry, leveraging its expertise to meet the evolving needs of the botanical processing market. The company’s recent financial performance indicates a commitment to growth, despite challenges reflected in net income figures. The strategic focus on innovative products and services positions Cryomass to capitalize on the increasing demand for cannabis and hemp processing solutions. With a dedicated team and a clear vision, the company aims to enhance its market presence and drive future growth.
AI Generated • Sep 28, 2026

Industry

Machinery

Employees

11

CEO

Christian Noël

Headquarters

Denver, CO 80204, US

CRYM Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-79560.21%

Net Income Margin

-95602.13%

Return on Equity

2032.67%

Return on Capital

N/A

Return on Assets

-1332.23%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

239.67M

Volume

500

Avg. Volume

1.05K

Financials (TTM)

Gross Profit

$37.74K

Operating Income

-$4.62M

EBITDA

-$8.08M

Operating Cash Flow

-$1.09M

Capital Expenditure

-$102.54K

Free Cash Flow

-$1.19M

Cash & ST Invst.

$183.44K

Total Debt

$3.32M

Cryomass Technologies Performance Analysis

Cryomass Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 13,552N/A
Cryomass Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31N/A
Q12024-03-31-60.9%
Q22024-06-30162.1%
Q32024-09-30-64.0%
Cryomass Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.06N/A
20222022-12-31USD -0.05-17.0%
20232023-12-31USD -0.0620.6%
Cryomass Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-141.4%
Q12024-03-3126.0%
Q22024-06-3041.6%
Q32024-09-3037.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$5.00K

N/A

Gross Profit

$5.00K

+116.6%

Gross Margin

100.00%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$33.33

N/A

Employees

6

N/A

Net Income

-$1.10M

+24.2%

EBITDA

-$924.00K

+29.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$183.44K

+1834.0%

Total Debt

$3.32M

+25.0%

Accounts Receivable

$6.19K

N/A

Inventory

$0.00

N/A

Long Term Debt

$594.80K

-75.5%

Short Term Debt

$2.73M

+1087.9%

Return on Assets

-13.32%

N/A

Return on Invested Capital

7.09%

N/A

Free Cash Flow

-$389.46K

+56.7%

Operating Cash Flow

-$285.54K

+67.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RDDTFRadient Technologies Inc.
$0.00+0.00%
TLLTFTILT Holdings Inc.
$0.00-50.00%
KAYSKaya Holdings, Inc.
$0.00+0.00%
KOANResonate Blends, Inc.
$0.00+50.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NKENike
$33.87-3.64%
NVDANvidia
$233.95+1.34%
SPCXSpace Exploration Technologies
$158.96+7.36%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$29.71-6.46%

Questions About CRYM

What is the current price of Cryomass Technologies?

Cryomass Technologies is trading at $0.00 per share.

What is the 52-week range for Cryomass Technologies?

Over the past 52 weeks, Cryomass Technologies has traded between $0.00 and $0.00.

How much debt does Cryomass Technologies have?

As of the most recent reporting period, Cryomass Technologies reported total debt of $4.49M.

How much cash does Cryomass Technologies have on hand?

Cryomass Technologies reported $49.22K in cash and cash equivalents in its most recent financial results.

What is Cryomass Technologies’s dividend yield?

Cryomass Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.